For instance, a large Mendelian randomization study demonstrated causal links between plasma protein expression (e.g., TNFAIP3, IL6R, LAYN) and the risk of allergic diseases, suggesting that similar strategies could be applied to uncover therapeutic targets in mastocytosis [14]. This evidence concerns the gene IL6R and mastocytosis.